![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB
Peng Cheng, Fan Jiang, Guiyuan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Peng Cheng, Fan Jiang, Guiyuan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Showing 23 citing articles:
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 50
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 50
PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses In Silico and In Vitro Assays
Fan Jiang, Cong Peng, Peng Cheng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 856-856
Open Access | Times Cited: 20
Fan Jiang, Cong Peng, Peng Cheng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 856-856
Open Access | Times Cited: 20
Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective
Zhaoyang Ye, Linsheng Li, Ling Yang, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 7
Zhaoyang Ye, Linsheng Li, Ling Yang, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 7
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development
Saurabh Chugh, Ritika Kar Bahal, Rohan Dhiman, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Saurabh Chugh, Ritika Kar Bahal, Rohan Dhiman, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Development and Evaluation of a Promising Biomarker for Diagnosis of Latent and Active Tuberculosis Infection
Cong Peng, Fan Jiang, Yinping Liu, et al.
Infectious Diseases & Immunity (2024) Vol. 4, Iss. 1, pp. 10-24
Open Access | Times Cited: 6
Cong Peng, Fan Jiang, Yinping Liu, et al.
Infectious Diseases & Immunity (2024) Vol. 4, Iss. 1, pp. 10-24
Open Access | Times Cited: 6
Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection
Jie Wang, Fan Jiang, Peng Cheng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Jie Wang, Fan Jiang, Peng Cheng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
A review on the development of bacterial multi-epitope recombinant protein vaccines via reverse vaccinology
Yuxin Li, Muhammad Haris Raza Farhan, Xiaohan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136827-136827
Closed Access | Times Cited: 4
Yuxin Li, Muhammad Haris Raza Farhan, Xiaohan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136827-136827
Closed Access | Times Cited: 4
A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation
Fan Jiang, Yong Han, Yinping Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Fan Jiang, Yong Han, Yinping Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing
Qi Liu, Jingli Du, Huiru An, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Qi Liu, Jingli Du, Huiru An, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Development of Multi-epitope mRNA Vaccine against Clostridioides difficile Using Reverse Vaccinology and Immunoinformatics Approaches
Caixia Tan, Yuanyuan Xiao, Ting Liu, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 4, pp. 667-683
Open Access | Times Cited: 3
Caixia Tan, Yuanyuan Xiao, Ting Liu, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 4, pp. 667-683
Open Access | Times Cited: 3
Discovering peptides and computational investigations of a multiepitope vaccine target Mycobacterium tuberculosis
Truc Ly Nguyen, Heebal Kim
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 3, pp. 391-405
Open Access | Times Cited: 3
Truc Ly Nguyen, Heebal Kim
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 3, pp. 391-405
Open Access | Times Cited: 3
Knowledge mapping of disease-modifying therapy (DMT) in multiple sclerosis (MS): A bibliometrics analysis
Fan Jiang, Fenghe Zhang, Yue Su, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31744-e31744
Open Access | Times Cited: 2
Fan Jiang, Fenghe Zhang, Yue Su, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31744-e31744
Open Access | Times Cited: 2
In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines
Koobashnee Pillay, Thamsanqa E. Chiliza, Sibusiso Senzani, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37536-e37536
Open Access | Times Cited: 1
Koobashnee Pillay, Thamsanqa E. Chiliza, Sibusiso Senzani, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37536-e37536
Open Access | Times Cited: 1
Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
Zhuang Li, Yilu Zhao, Ling Yang, et al.
Decoding Infection and Transmission (2024) Vol. 2, pp. 100026-100026
Open Access | Times Cited: 1
Zhuang Li, Yilu Zhao, Ling Yang, et al.
Decoding Infection and Transmission (2024) Vol. 2, pp. 100026-100026
Open Access | Times Cited: 1
Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
Zhuang Li, Awais Ali, Ling Yang, et al.
Infectious Medicine (2024) Vol. 3, Iss. 4, pp. 100148-100148
Open Access | Times Cited: 1
Zhuang Li, Awais Ali, Ling Yang, et al.
Infectious Medicine (2024) Vol. 3, Iss. 4, pp. 100148-100148
Open Access | Times Cited: 1
Design and development of a multiāepitope vaccine for the prevention of latent tuberculosis infection
Fan Jiang, Lingling Wang, Jie Wang, et al.
Medicine Advances (2023) Vol. 1, Iss. 4, pp. 361-382
Open Access | Times Cited: 4
Fan Jiang, Lingling Wang, Jie Wang, et al.
Medicine Advances (2023) Vol. 1, Iss. 4, pp. 361-382
Open Access | Times Cited: 4
Design of a novel multi-epitope vaccine candidate against endometrial cancer using immunoinformatics and bioinformatics approaches
Xiaohan Li, Haicheng Wen, Xiao Xiao, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11521-11537
Closed Access | Times Cited: 2
Xiaohan Li, Haicheng Wen, Xiao Xiao, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11521-11537
Closed Access | Times Cited: 2
Excluding Participants With Mycobacteria Infections From Clinical Trials: A Critical Consideration in Evaluating the Efficacy of BCG Against COVID-19
Wenping Gong, Jingli Du
Journal of Korean Medical Science (2023) Vol. 38, Iss. 42
Open Access | Times Cited: 2
Wenping Gong, Jingli Du
Journal of Korean Medical Science (2023) Vol. 38, Iss. 42
Open Access | Times Cited: 2
Efficacy and Safety of Baihe Gujin Decoction Combined with Anti-Tuberculosis Drugs for Treatment of Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis
Yilu Zhao, Yiran Han, Huiru An, et al.
(2024)
Closed Access
Yilu Zhao, Yiran Han, Huiru An, et al.
(2024)
Closed Access
Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies
Priyanga Paranthaman, V. Shanthi
Frontiers in Physics (2024) Vol. 12
Open Access
Priyanga Paranthaman, V. Shanthi
Frontiers in Physics (2024) Vol. 12
Open Access
Structural proteomics guided annotation of vaccine targets and designing of multi-epitopes vaccine to instigate adaptive immune response against Francisella tularensis
Abbas Khan, Syed Shujait Ali, Asghar Khan, et al.
Microbial Pathogenesis (2024) Vol. 194, pp. 106777-106777
Closed Access
Abbas Khan, Syed Shujait Ali, Asghar Khan, et al.
Microbial Pathogenesis (2024) Vol. 194, pp. 106777-106777
Closed Access
In silico vaccine design for Yersinia enterocolitica: A comprehensive approach to enhanced immunogenicity, efficacy and protection
Munazza Kanwal, Amina Basheer, Muhammad Bilal, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113241-113241
Closed Access
Munazza Kanwal, Amina Basheer, Muhammad Bilal, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113241-113241
Closed Access
A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
Mona Shafaghi, Zohreh Bahadori, Seyed Mahmoud Barzi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1
Mona Shafaghi, Zohreh Bahadori, Seyed Mahmoud Barzi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1